AIG Posts Q3 Results as Options Optimism Fades

American International Group reported its Q3 earnings on November 4, closing at $80.53 after falling 2.3% on the day, a retreat that partially reversed a 7.5% gain built over the prior month as pre-earnings enthusiasm gave way to a more measured read of the results.

The sharpest signal shift this week came in options. Through September and most of October, the put/call ratio ran consistently above 1.28, reflecting strong demand for downside protection. That defensive posture unwound sharply into earnings week, with the PCR dropping to 0.89 four days ago before drifting back up to 0.93 by Tuesday. At roughly 1.2 standard deviations below its 20-day average of 1.13, the ratio still leans toward calls relative to recent norms, but the direction of travel has reversed. The pre-earnings call enthusiasm has partially unwound, and the PCR's drift higher through the week is consistent with investors closing speculative positions after the release rather than adding new ones.

Short positioning offers no meaningful story on either side. Short interest at 1.97% of the free float is low and largely unmoved over the week, with the borrowing cost at 0.49% and availability effectively unlimited. With nearly 485 million shares available to lend against roughly 10.6 million sold short, the lending market is a non-factor here.

The analyst picture leans constructive but with caveats. UBS carries a Buy and a $100 target, the most optimistic on the Street. Keefe, Bruyette and Woods maintains an Outperform at $90. Against that, Morgan Stanley holds an Equal-Weight at $80, essentially flat to the current price, and both Wells Fargo and Mizuho trimmed their targets in October while keeping neutral ratings. The consensus target of $88 implies roughly 9% upside from Tuesday's close. The forward earnings growth score ranks in the 96th percentile against the broader universe, a striking figure, though near-term EPS momentum scores of 55 and 47 on the 30-day and 90-day windows suggest the longer-run growth story has not yet translated into consistent estimate upgrades. The stock trades at 9.3 times earnings with a price-to-book below 1.0, valuation that looks undemanding if underwriting can stabilise.

The bear case centres on exactly that uncertainty. Weakness in the Convex unit and the EG acquisition's underwriting results has been a recurring drag, and several analysts cut targets in early October ahead of this print, citing a more competitive environment and a slower pace of buybacks. The bull case rests on net investment income, which rose 13.1% year over year to $881 million last quarter, and on Convex's 25% premium growth CAGR over three years. Those two arguments are likely to be tested directly by whatever the Q3 numbers show on underwriting margins and investment returns.

One institutional data point worth noting: BlackRock added over 2.2 million shares in the most recent reported quarter to reach 9.4% of shares outstanding, the largest holder on the register. Vanguard entities collectively hold another 12%-plus across separate vehicles, though one Vanguard vehicle's 13G filing from March showed a move from 12.4% to effectively zero, reflecting internal restructuring rather than disposal. Executive Chairman Peter Zaffino sold roughly $18.1 million of stock in August under a pre-arranged 10b5-1 plan, the kind of scheduled sale that carries less signal than a discretionary transaction, but the net insider position over the past 90 days is negative at roughly $18.1 million sold.

Wikipedia attention spiked to a z-score of 2.1 against AIG's own 90-day history around October 22, the highest retail-attention reading in the tracked window. That elevated curiosity coincided with the final stretch of pre-earnings positioning, and the actual print is now the focus. The question going forward is whether Q3 underwriting margins show the stabilisation that the bull case requires, or whether Convex and EG results once again limit the narrative to investment income and discount valuation.